Aspiring to Excellence is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Novartis and UCB. It is an award programme designed to encourage and recognise service improvement in axial SpA (AS) care.
It will provide a focal point from which professionals can explore and test approaches to reduce the delay to diagnosis and improve axial SpA (AS) care and patient experience. The knowledge and experience generated will be shared in real-time across the UK and internationally to help stimulate across-the-board improvements in care.
Aspiring to Excellence is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Novartis and UCB. It is an essential component of our Every Patient, Every Time campaign.
Our Aspiring to Excellence programme is now closed for applications in 2019.
Applications for our first cohort closed on 31 July 2019. We will be inviting applications again in early 2020 for our second cohort so please do keep an eye out on this page for further details. For any questions please contact Anna McGilvray, Programme Manager for Aspiring to Excellence. You can also sign up to our Health Professionals E-News to stay updated on the latest information about NASS and axial SpA, including AS.